Literature DB >> 8968925

Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults.

E Lyamuya1, U Bredberg-Rådén, J Albert, O Grankvist, V Msangi, C Kagoma, F Mhalu, G Biberfeld.   

Abstract

This study compared the performance of several in-house nested PCR systems and the Amplicor human immunodeficiency virus type 1 (HIV-1) PCR kit in the detection of HIV-1 DNA in Tanzanian samples prepared by two different methods. All six of the in-house primer sets evaluated had a higher sensitivity for HIV DNA detection in samples prepared by the Amplicor PCR sample preparation method than in those prepared by the Ficoll-Isopaque (FIP) density gradient centrifugation method. A sensitivity of 100% was achieved by combining two in-house primer sets. The sensitivity of the standard Amplicor HIV-1 PCR kit was only 59%, whereas a modified Amplicor HIV-1 PCR test had a sensitivity of 98%. Our data show that Tanzanian samples prepared by the Amplicor preparation method are more suitable for HIV-1 PCR testing than samples prepared by the FIP method. The modified, but not the standard, Amplicor HIV-1 PCR kit provides an alternative to the nested in-house PCR technique for the diagnosis of HIV infection.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Developing Countries; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hiv Serodiagnosis; Laboratory Examinations And Diagnoses; Research Report; Tanzania

Mesh:

Substances:

Year:  1997        PMID: 8968925      PMCID: PMC229556          DOI: 10.1128/jcm.35.1.278-280.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Evaluation and comparison of the Amplicor HIV-1 PCR kit with an 'in-house' nested PCR.

Authors:  K Fransen; I van Kerckhoven; P Piot; G van der Groen
Journal:  Clin Diagn Virol       Date:  1995-12

2.  Low human immunodeficiency virus titer and polymerase chain reaction false-negatives.

Authors:  M Zazzi; L Romano; A Brasini; P E Valensin
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

3.  Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridisation to amplified viral DNA.

Authors:  M Loche; B Mach
Journal:  Lancet       Date:  1988-08-20       Impact factor: 79.321

4.  Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes.

Authors:  J Louwagie; F E McCutchan; M Peeters; T P Brennan; E Sanders-Buell; G A Eddy; G van der Groen; K Fransen; G M Gershy-Damet; R Deleys
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

5.  vpu and env sequence variability of HIV-1 isolates from Tanzania.

Authors:  W Siwka; A Schwinn; K Baczko; I Pardowitz; F Mhalu; J Shao; A Rethwilm; V ter Meulen
Journal:  AIDS Res Hum Retroviruses       Date:  1994-12       Impact factor: 2.205

Review 6.  The polymerase chain reaction, a review of the practical limitations for human immunodeficiency virus diagnosis.

Authors:  J P Clewley
Journal:  J Virol Methods       Date:  1989-08       Impact factor: 2.014

7.  Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers.

Authors:  J Albert; E M Fenyö
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

8.  Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection.

Authors:  J E Brinchmann; J Albert; F Vartdal
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

9.  Extensive variation of human immunodeficiency virus type-1 in vivo.

Authors:  M S Saag; B H Hahn; J Gibbons; Y Li; E S Parks; W P Parks; G M Shaw
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

10.  Early diagnosis of human immunodeficiency virus infection in children less than 6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques.

Authors:  W Borkowsky; K Krasinski; H Pollack; W Hoover; A Kaul; T Ilmet-Moore
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

View more
  8 in total

1.  Salmonella meningitis and a green iguana.

Authors:  W I Sam; A D Mackay
Journal:  J R Soc Med       Date:  2000-06       Impact factor: 5.344

2.  Acute myocardial infarction without raised creatine kinase activity.

Authors:  T Nagai
Journal:  J R Soc Med       Date:  2000-06       Impact factor: 5.344

3.  A multiple-sclerosis-like syndrome associated with glue-sniffing.

Authors:  M B Davies; S J Weatherby; N Haq; S J Ellis
Journal:  J R Soc Med       Date:  2000-06       Impact factor: 5.344

4.  Alimentary hyperglycaemia mistaken for diabetes mellitus.

Authors:  B O Saeed; N A Morris; G H Handley
Journal:  J R Soc Med       Date:  2000-06       Impact factor: 5.344

5.  Epstein-Barr virus infection mimicking extrahepatic biliary obstruction.

Authors:  G Barlow; R Kilding; S T Green
Journal:  J R Soc Med       Date:  2000-06       Impact factor: 5.344

6.  Angel's trumpet and the eye.

Authors:  H C Roemer; H von Both; W Foellmann; K Golka
Journal:  J R Soc Med       Date:  2000-06       Impact factor: 5.344

7.  The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.

Authors:  C Tscherning-Casper; N Papadogiannakis; M Anvret; L Stolpe; S Lindgren; A B Bohlin; J Albert; E M Fenyö
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Impaired B cells survival upon production of inflammatory cytokines by HIV-1 exposed follicular dendritic cells.

Authors:  Farideh Sabri; Alejandro Prados; Raquel Muñoz-Fernández; Rebecka Lantto; Pablo Fernandez-Rubio; Aikaterini Nasi; Sylvie Amu; Jan Albert; Enrique Garcia Olivares; Francesca Chiodi
Journal:  Retrovirology       Date:  2016-09-05       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.